Markets › India › NSE › APLLTD

Alembic Pharmaceuticals Ltd

NSE:APLLTDHealthcare

₹790.35+0.11%At closeAt close · Mon 19 Oct · ≈ AED 30.49 · Market cap $1.63B · Next earnings Tue 10 Nov

Ratio	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026	Current · undated	YoY
Gross margin	75.1%	71.8%	68.6%	71.2%	71.8%	45.1%	—	—
Operating margin	43.2%	34.5%	35.0%	40.3%	40.5%	10.9%	10.9%	+0.0 pts
Net margin	21.3%	9.8%	6.1%	9.9%	8.7%	9.2%	9.2%	+0.0 pts
EBITDA margin	27.2%	16.2%	12.3%	14.7%	14.8%	15.1%	—	—
Return on equity	22.6%	9.9%	7.8%	12.8%	11.2%	11.9%	11.9%	+0.0 pts
Return on assets	17.1%	7.3%	5.5%	9.6%	7.5%	7.7%	7.7%	+0.0 pts
Return on capital employed	43.0%	33.9%	43.6%	50.3%	50.4%	13.0%	—	—
Debt / equity	0.1×	0.1×	0.2×	0.1×	0.2×	0.3×	0.3×	+0.1%
Debt / assets	8.7%	10.1%	11.7%	8.0%	16.2%	16.3%	—	—
Interest coverage	145.5×	103.3×	39.5×	44.6×	34.3×	8.5×	—	—
Current ratio	2.1×	1.7×	1.8×	2.1×	1.7×	1.8×	1.8×	+0.0%
Quick ratio	0.9×	0.7×	0.9×	1.0×	0.7×	0.8×	—	—
Cash ratio	0.1×	0.0×	0.0×	0.1×	0.0×	0.1×	0.1×	+0.0%
Asset turnover	0.8×	0.7×	0.9×	1.0×	0.9×	0.8×	—	—
Inventory turnover	0.9×	0.9×	1.2×	1.1×	0.8×	1.6×	—	—
Receivables turnover	15.2×	6.5×	5.4×	6.1×	4.8×	5.0×	—	—
Dividend payout	0.0%	52.8%	57.5%	25.5%	37.1%	32.0%	—	—

Margins, returns, leverage and liquidityUpdated Tue 31 Mar ·

ⓘ

Current snapshot ratios have no reporting date and are shown separately from fiscal periods.